Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment.

ABSTRACT:

Background

Significant adverse events (AE) during cancer therapy disrupt treatment and escalate to emergency admissions. Approaches to improve the timeliness and accuracy of AE reporting may improve safety and reduce health service costs. Reporting AE via patient reported outcomes (PROs), can improve clinician-patient communication and making data available to clinicians in 'real-time' using electronic PROs (ePROs) could potentially transform clinical practice by providing easily accessible records to guide treatment decisions. This manuscript describes the development of eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and aDvice) is a National Institute for Health Research-funded programme, a system for patients to self-report and manage AE online

SUBMITTER: Holch P 

PROVIDER: S-EPMC5834137 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature